ENDOCRINE & METABOLIC PSI has conducted a number of large and small studies in endocrinology and metabolic disorders since 1995. On-time delivery has always been the key focus ensuring repeat business from pharmaceutical and biotech customers working in the metabolic area. Being a full service global CRO, our clinical trial reach spans across 50+ countries and the geographic regions; North America, Latin America, Asia- Pacific, Europe and South Africa. This coverage has given PSI invaluable clinical trial experience while establishing working relationships with Key Opinion Leaders and investigators in the following areas:
Diabetes Mellitus in CAPD & APD Patients Diabetes Mellitus Type II † Diabetes Mellitus Type I Hunter Syndrome † Hypothyroidism Osteoporosis † Sanfilippo Syndrome † †
includes Pediatric subjects
The PSI monitoring team has always set the standard for excellence in performance on the study. Clinical Trial Manager, USA
For more information about PSI, please visit our website WWW.PSI-CRO.COM or reach us at CONTACT@PSI-CRO.COM
PSI CRO AG Corporate Headquarters Baarerstrasse 113a 6300 Zug, Switzerland Tel: +41 41 228 10 00
Global Office Locations North America Ft. Washington, PA Burlingame, CA San Francisco, CA
Latin America Buenos Aires, Argentina
Europe Oxford, UK Munich, Germany Neusiedl am See, Austria Minsk, Belarus Sofia, Bulgaria Prague, Czech Republic Tallinn, Estonia Budapest, Hungary Milan, Italy Warsaw, Poland Bucharest, Romania Belgrade, Serbia Kiev, Ukraine Russian Federation: St. Petersburg, Moscow, Novosibirsk
Operational Presence by Region North America / Europe / Latin America Asia-Pacific / South Africa
WWW.PSI-CRO.COM